- Home
- CRGX vs FMBH Comparison
CRGX vs FMBH Comparison
Compare CRGX & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- FMBH
- Stock Information
- Founded
- CRGX 2021
- FMBH 1865
- Country
- CRGX United States
- FMBH United States
- Employees
- CRGX N/A
- FMBH N/A
- Industry
- CRGX
- FMBH Major Banks
- Sector
- CRGX
- FMBH Finance
- Exchange
- CRGX Nasdaq
- FMBH Nasdaq
- Market Cap
- CRGX 964.5M
- FMBH 920.6M
- IPO Year
- CRGX 2023
- FMBH N/A
- Fundamental
- Price
- CRGX $16.00
- FMBH $41.99
- Analyst Decision
- CRGX Strong Buy
- FMBH Buy
- Analyst Count
- CRGX 7
- FMBH 5
- Target Price
- CRGX $30.33
- FMBH $43.40
- AVG Volume (30 Days)
- CRGX 167.8K
- FMBH 63.7K
- Earning Date
- CRGX 11-12-2024
- FMBH 10-31-2024
- Dividend Yield
- CRGX N/A
- FMBH 2.29%
- EPS Growth
- CRGX N/A
- FMBH N/A
- EPS
- CRGX N/A
- FMBH 3.24
- Revenue
- CRGX N/A
- FMBH $316,387,000.00
- Revenue This Year
- CRGX N/A
- FMBH N/A
- Revenue Next Year
- CRGX N/A
- FMBH $4.32
- P/E Ratio
- CRGX N/A
- FMBH $12.94
- Revenue Growth
- CRGX N/A
- FMBH 22.37
- 52 Week Low
- CRGX $13.56
- FMBH $28.86
- 52 Week High
- CRGX $33.92
- FMBH $43.52
- Technical
- Relative Strength Index (RSI)
- CRGX 32.69
- FMBH 58.60
- Support Level
- CRGX $19.96
- FMBH $41.29
- Resistance Level
- CRGX $23.00
- FMBH $43.52
- Average True Range (ATR)
- CRGX 1.79
- FMBH 1.30
- MACD
- CRGX -0.58
- FMBH 0.27
- Stochastic Oscillator
- CRGX 7.04
- FMBH 77.86
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. It also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.